TAK-029

TAK-029 is a potent GP IIb/IIIa antagonist. TAK-029 has potent antithrombotic effects with bleeding time (BT) prolongation in arterial thrombosis models. TAK-029 can be used for the research of various arterial thrombotic diseases[1].

Product Specifications

CAS Number

[176655-58-6]

UNSPSC

12352005

Target

Integrin

Type

Reference compound

Related Pathways

Cytoskeleton

Applications

Neuroscience-Neuromodulation

Field of Research

Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/tak-029.html

Smiles

O=C(CNC(C1=CC=C(C(N)=N)C=C1)=O)N([C@H]2CC(OC)=O)CCN(CC(O)=O)C2=O

Molecular Formula

C19H23N5O7

Molecular Weight

433.42

References & Citations

[1]Kawamura M, et al. Effects of TAK-029, a novel GPIIb/IIIa antagonist, on arterial thrombosis in guinea pigs, dogs and monkeys. Thromb Res. 1997 May 15;86 (4) :275-85.